However, LCN2 administration showed more pronounced effects on iFGF23 levels in Col4a3KO mice with CKD, confirming that impaired FGF23 cleavage contributes to elevated serum iFGF23 levels in CKD.8,53,54. The gene discussed is LCN2; the disease is chronic kidney disease.